Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,400.00
+310.00 (4.37%)
Last updated: Jun 4, 2026, 2:24 PM KST
Market Cap150.52B -42.6%
Revenue (ttm)210.51B -3.3%
Net Income-36.42B
EPS-1,714.21
Shares Out 21.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume82,838
Open7,010.00
Previous Close7,090.00
Day's Range7,010.00 - 7,480.00
52-Week Range6,870.00 - 12,860.00
Beta0.43
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Sam... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

In 2025, KRX:000520's revenue was 210.25 billion, a decrease of -4.30% compared to the previous year's 219.70 billion. Losses were -34.66 billion, 515.8% more than in 2024.

Financial Statements